UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Dong-A ST, Dongwha Pharm lose status of innovative drugmaker
by Jeong Sae-im
2019-07-05 16:00
Lilly aims to reshape Korea’s breast cancer treatment market
by Lee Han-soo
2019-07-05 16:00
‘Truvada will improve Korea's HIV treatment environment’
by Lee Han-soo
2019-07-04 10:53
Janssen nixes deal with Hanmi over antidiabetic obesity drug
by Jeong Sae-im
2019-07-04 10:52
Bukwang, UK university to co-develop Parkinson’s disease treatment
by Lee Han-soo
2019-07-03 15:03
라인
Handok releases Fabry disease treatment
by Lee Han-soo
2019-07-02 16:19
26 new drugs approved in H1
by Lee Hye-seon
2019-07-02 14:31
[News Focus]Yuhan pulled off $3.1 billion licensing deals in one year. How?
by Jeong Sae-im
2019-07-02 12:11
Huons launches new osteoarthritis treatment
by Lee Han-soo
2019-07-01 15:13
Eli Lilly Korea gains further reimbursement for psoriasis treatment Taltz
by Lee Han-soo
2019-07-01 14:27
라인
BMS Korea files administrative suit to appeal Eliquis price cut
by Kim Yun-mi
2019-07-01 14:16
Yuhan signs $870 million licensing deal with Boehringer Ingelheim
by Lee Han-soo
2019-07-01 14:09
'Proteogenomics will improve ability to prevent, diagnose and treat cancer at molecular level'
by Lee Han-soo
2019-06-28 17:43
Lilly anticipates Trulicity’s growth as GLP-1 receptor antagonists get popular
by Kim Yun-mi
2019-06-28 16:12
Samsung Bioepis readies phase-3 trial on Soliris biosimilar
by Lee Hye-seon
2019-06-27 17:14
라인
Eutilex unveils immunotherapy development strategy
by Lee Han-soo
2019-06-27 16:51
Voluntary nullifications of drug license tripled in H1
by Lee Hye-seon
2019-06-26 14:25
Seoul Pharma to export erectile dysfunction treatment to Azerbaijan
by Lee Han-soo
2019-06-26 13:58
Novartis’ Tasigna confirms long-term success for chronic myelogenous leukemia
by Lee Han-soo
2019-06-26 11:39
Huons Global launches new BTX in Korea
by Lee Han-soo
2019-06-26 10:52
-
이전
41
42
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top